Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Randolph

Showing results (291-300 of 487) with videos related to

Pageof 49
Sort By:
Immunology|March 25, 2010
Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological modelYifan Ma, Louis Poisson, Guzman Sanchez-Schmitz, et al.
The Journal of Clinical Investigation|September 1, 2023
The emerging importance of lymphatics in health and disease: an NIH workshop reportBabak J Mehrara, Andrea J Radtke, Gwendalyn J Randolph, et al.
Frontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.
The Journal of Clinical Investigation|April 21, 2011
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regressionStephane Potteaux, Emmanuel L Gautier, Susan B Hutchison, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 16, 2014
A single institution experience in compliance with universal screening for Lynch syndrome in colorectal cancerAmy L Hill, Kirandeep K Sumra, Marcia M Russell, et al.
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trialFairooz F Kabbinavar, Joseph Schulz, Michael McCleod, et al.
Neuroreport|July 14, 2006
Functional magnetic resonance imaging of executive control in bipolar disorderRobert M Roth, Nancy S Koven, John J Randolph, et al.
The Journal of Experimental Medicine|August 24, 2016
MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytesKi-Wook Kim, Jesse W Williams, Ya-Ting Wang, et al.
Anticancer Research|March 10, 2015
Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancerJ Randolph Hecht, Tony R Reid, Christopher R Garrett, et al.
Pageof 49

Showing results (291-300 of 487) with videos related to

Sort By:
Pageof 49
Immunology|March 25, 2010
Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological modelYifan Ma, Louis Poisson, Guzman Sanchez-Schmitz, et al.
The Journal of Clinical Investigation|September 1, 2023
The emerging importance of lymphatics in health and disease: an NIH workshop reportBabak J Mehrara, Andrea J Radtke, Gwendalyn J Randolph, et al.
Frontiers in Oncology|February 20, 2026
Advancements in intratumoral therapies for liver tumorsSteven S Raman, Neal R Cutler, John J Sramek, et al.
The Journal of Clinical Investigation|April 21, 2011
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regressionStephane Potteaux, Emmanuel L Gautier, Susan B Hutchison, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 16, 2014
A single institution experience in compliance with universal screening for Lynch syndrome in colorectal cancerAmy L Hill, Kirandeep K Sumra, Marcia M Russell, et al.
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trialFairooz F Kabbinavar, Joseph Schulz, Michael McCleod, et al.
Neuroreport|July 14, 2006
Functional magnetic resonance imaging of executive control in bipolar disorderRobert M Roth, Nancy S Koven, John J Randolph, et al.
The Journal of Experimental Medicine|August 24, 2016
MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytesKi-Wook Kim, Jesse W Williams, Ya-Ting Wang, et al.
Anticancer Research|March 10, 2015
Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancerJ Randolph Hecht, Tony R Reid, Christopher R Garrett, et al.
Pageof 49